Meet Kathleen Ragland, who participated in Phase I of Tisch MSRCNY's FDA-Approved Stem Cell Clinical Trial for MS. Learn about her remarkable improvement.Cast: Tisch MSRCNY VideosTags: multiple sclerosis, MS, myelin repair, stem cells, stem cells for MS, stem cell treatment, Tisch MSRCNY and MS research